KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Short-term Investments (2022 - 2026)

Castle Biosciences' Short-term Investments history spans 4 years, with the latest figure at $182.8 million for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 5.41% to $182.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $182.8 million, a 5.41% increase, with the full-year FY2025 number at $182.8 million, up 5.41% from a year prior.
  • Short-term Investments hit $182.8 million in Q4 2025 for Castle Biosciences, down from $202.0 million in the prior quarter.
  • Over the last five years, Short-term Investments for CSTL hit a ceiling of $202.0 million in Q3 2025 and a floor of $117.2 million in Q1 2023.
  • Historically, Short-term Investments has averaged $160.7 million across 4 years, with a median of $164.8 million in 2024.
  • Biggest five-year swings in Short-term Investments: increased 5.08% in 2023 and later soared 34.31% in 2024.
  • Tracing CSTL's Short-term Investments over 4 years: stood at $135.7 million in 2022, then grew by 6.32% to $144.3 million in 2023, then increased by 20.22% to $173.4 million in 2024, then grew by 5.41% to $182.8 million in 2025.
  • Business Quant data shows Short-term Investments for CSTL at $182.8 million in Q4 2025, $202.0 million in Q3 2025, and $193.7 million in Q2 2025.